calendar
2,359 catalysts · 4,876 phase readout · 2,350 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
next 91 dayslessmore
MonWedFri
2,359 catalysts · 4,876 phase readout · 2,350 8k filing · 286 earnings · 275 pdufa · 166 phase 2 completion · 71 phase 1 completion
Items: 5.02
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 3.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.03, 5.07, 9.01
Items: 2.02, 9.01
Items: 5.02
Items: 4.02
Items: 5.02
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 3.02, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 9.01
Items: 1.01, 2.03, 3.01, 3.03, 9.01
Items: 2.05, 7.01, 9.01
Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 5.07, 9.01
Items: 5.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 9.01